Presentation is loading. Please wait.

Presentation is loading. Please wait.

BIOLOGICAL EFFICIENCY OF A THERAPEUTIC PROTON BEAM: A STUDY OF HUMAN MELANOMA CELL LINE I. Petrović 1, A. Ristić-Fira 1, D. Todorović 1, L. Korićanac 1,

Similar presentations


Presentation on theme: "BIOLOGICAL EFFICIENCY OF A THERAPEUTIC PROTON BEAM: A STUDY OF HUMAN MELANOMA CELL LINE I. Petrović 1, A. Ristić-Fira 1, D. Todorović 1, L. Korićanac 1,"— Presentation transcript:

1 BIOLOGICAL EFFICIENCY OF A THERAPEUTIC PROTON BEAM: A STUDY OF HUMAN MELANOMA CELL LINE I. Petrović 1, A. Ristić-Fira 1, D. Todorović 1, L. Korićanac 1, L. Valastro 2 and G. Cuttone 2 1 Vinča Institute of Nuclear Sciences, Belgrade, Serbia and Montenegro 2 Istituto Nazionale di Fisica Nucleare, LNS, Catania, Italy

2 Advantages of protons compared to conventional radiation: - targeting radiation dose precisely into the tumour, - sparing neighboring healthy tissue.

3 Physical qualities of protons: small lateral scattering, energy loss per unit length – linear energy transfer (LET) – increases while the proton slows down, range directly proportional to energy, depth-dose distribution: - slow increase of dose – plateau region, - rapid build-up to a sharp maximum almost at the end of range – the Bragg peak, - distal swift fall-off.

4 Practical approach – to deliver uniform dose over large volume at a given depth: Spread-out Bragg peak (SOBP) – modulation of proton energy at the price of a slight increase of the entrance dose. Modulation of proton energy, i.e., range, is achieved by degrading initial proton energy which results in superimposition of a number of monoenergetic proton beams of closely spaced energies, thus the position of the Bragg peak is pooled back towards the beam source as energy is reduced. The Bragg peak and SOBP have a higher LET than the beam entering the tissue.

5 National Association for Proton Therapy, USA

6 Goal Evaluation of physical and radiobiological parameters of the CATANA (Centro di Adro Terapia e Applicazzioni Nucleari Avanzati) proton beam facility, used for the treatment of eye melanoma. Assessment of parameters describing the level of cell radio- sensitivity and efficiency of different radiation qualities (highly ionising radiation - protons vs. conventional radiation -  -rays) needed to analyse and predict success of therapeutic irradiations.

7 The CATANA (Centro di Adro Terapia e Applicazzioni Nucleari Avanzati) treatment facility, INFN - LNS, Catania, Italy

8 Irradiation conditions Irradiations at 6.6, 16.3, 25.0 and 26.0 mm in Perspex (Polymethyl methacrylate - PMMA) within the SOBP of the 62 MeV proton beam (produced by the superconducting cyclotron at the CATANA treatment facility, INFN, LNS – Catania). Reference dosimetry – plane - parallel PTW 34045 Markus ionization chamber calibrated according to IAEA code of practice (IAEA-TRS-398 2000). Single doses delivered to the cells: 2, 4, 8, 12 and 16 Gy, at dose rate of 15 Gy/min. Irradiations with γ-rays, at the same dose levels, were performed using 60 Co source at the Vinca Institute of Nuclear Sciences in Belgrade, at average dose rate of 1 Gy/min. All cell irradiations were carried out in air at room temperature.

9 Bragg peak Figure 1. Depth dose distribution of the Bragg peak in Perspex of the 62 MeV proton beam produced at the CATANA treatment facility in the INFN-LNS, Catania.

10 SOBP Figure 2. Depth dose distribution of the spread-out Bragg peak in Perspex of the 62 MeV proton beam produced at the CATANA treatment facility in the INFN-LNS, Catania. Arrows correspond to irradiation positions at 6.6 mm (A), 16.3 mm (B), 25 mm (C) and 26 mm (D).

11 Table 1. Irradiation position parameters in SOBP for HTB140 cells Irradiation Depth in Dose Ē * position Perspex (mm) (%) (MeV) A 6.6 87.24±2.61 50.90±4.33 B 16.3 99.42±0.58 34.88±2.15 C 25.0 102.21±3.43 11.74±1.23 D 26.0 32.12±4.27 5.99±1.36 * mean energy

12 Cell culture conditions Irradiation of exponentially growing HTB140 human melanoma cells. Plating efficiency (PE) for HTB140 cells - approximately 60 – 70 %. Doubling time (Td) for HTB140 cells - 24±2,7 h. Biological assays Cell viability: - clonogenic assay (CA), - microtetrasolium (MTT) assay, - sulforhodamine B (SRB) assay.

13 Assessment of radiobiological effects of protons Surviving fraction as a function of dose and/or depth. Surviving fraction at 2 Gy (SF2) – level of radio-sensitivity. Relative biological effectiveness (RBE) – inactivation capacity of irradiated cells: –RBE(2Gy,  ) - ratio of 2 Gy  –ray dose and the proton dose generating the same inactivation level as that of  -rays, –strongly depends on LET, reaching its maximum value at ~ 100 keV/µm, corresponding to proton energy of ~ 65 keV. High-LET radiations, i.e., protons and heavy ions, have more efficient biological effectiveness than low-LET radiations, such as X-rays or  -rays.

14 CA Figure 3. Dose dependent surviving fractions, estimated by clonogenic assay, of HTB140 melanoma cells irradiated with  -rays and protons. Irradiation position within the proton spread-out Bragg peak correspond to 6.6 mm (A), 16.3 mm (B), 25 mm (C) and 26 mm (D) depth in Perspex.

15 CA MTT SRB Figure 4.

16 Table 2. SF2 values at different depths in SOBP for HTB140 cells  -rays single 0.874±0.074 0.875±0.078 0.848±0.054 protons A (6.6 mm) 0.825±0.061 0.774±0.033 0.806±0.018 B (16.3 mm) 0.748±0.103 0.691±0.015 0.722±0.022 C (25.0 mm) 0.562±0.036 0.520±0.015 0.584±0.081 D (26.0 mm) 0.578±0.064 0.532±0.036 0.596±0.011 Irradiation CA  MTT  SRB  position  clonogenic assay,  microtetrasolium assay,  sulforhodamine B assay.

17 Figure 5. Surviving fractions of HTB140 melanoma cells irradiated at 2, 4, 8, 12 and 16 Gy as a function of depth, estimated by clonogenic assay. Irradiation position within the proton spread-out Bragg peak correspond to 6.6 mm (A), 16.3 mm (B), 25 mm (C) and 26 mm (D) depth in Perspex. CA

18 MTT SRB Figure 6.

19 Table 3. RBE(2Gy,  ) values at different depths in SOBP for HTB140 cells A (6.6 mm) 1.39±0.06 1.89±0.09 1.32±0.07 B (16.3 mm) 2.14±0.11 2.76±0.18 2.02±0.14 C (25.0 mm) 4.63±0.23 5.28±0.31 3.32±0.21 D (26.0 mm) 4.26±0.28 4.89±0.37 3.08±0.27  clonogenic assay,  microtetrasolium assay,  sulforhodamine B assay. Irradiation CA  MTT  SRB  position

20 Conclusions Surviving fractions at 2 Gy (SF2), throughout the whole spread out Bragg peak (SOBP), indicated high level of radio- resistance of HTB140 cells. For the dose range comprising small and therapeutic doses, relatively high level of survival was revealed, moderately decreasing when changing irradiation position from the proximal to the distal end of SOBP. A rather important rate of the fall of survival at small doses (2 and 4 Gy) was significantly reduced for therapeutic doses (8 to 16 Gy), implying even relatively higher level of radio- resistance than pointed out by SF2.

21 Conclusions  RBE values indicated significant level of proton induced cell inactivation, even though it was shown that HTB140 cells are among the most radio-resistant cells.  RBE values considerably increased when approaching the distal end of SOBP.  At the distal declining edge of SOBP, where the dose intensity was less than half of the full dose intensity of SOBP, the killing ability of protons was close to that observed at the distal end of SOBP.


Download ppt "BIOLOGICAL EFFICIENCY OF A THERAPEUTIC PROTON BEAM: A STUDY OF HUMAN MELANOMA CELL LINE I. Petrović 1, A. Ristić-Fira 1, D. Todorović 1, L. Korićanac 1,"

Similar presentations


Ads by Google